Zealand’s Proprietary Pipeline Now Key Focus Ahead Of CEO Transition
This article was originally published in The Pink Sheet Daily
Executive Summary
Supported by a solid base of partnered products, Denmark’s Zealand Pharma is now building a proprietary pipeline that it hopes to grow further under a new chief executive.